Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Carpenter

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reports|October 1, 1986
Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: a Southeastern Cancer Study Group trialJ Keller, A Bartolucci, J T Carpenter, et al.
Cancer|August 1, 1991
Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndromeB E Harris, J T Carpenter, R B Diasio
The Journal of Clinical Investigation|January 1, 1988
Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicityR B Diasio, T L Beavers, J T Carpenter
Virginia Medical|March 1, 1982
Remission of immune hemolytic anemia after removal of ovarian dermoid cyst: case reportM D Murad, D N Mohler, J T Carpenter
Cancer|April 1, 1991
Weight gain with breast cancer adjuvant treatmentE G Levine, J M Raczynski, J T Carpenter
Archives of Internal Medicine|August 1, 1979
Bone marrow necrosis and degenerationM J Norgard, J T Carpenter, M E Conrad
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapyZ Lu, R Zhang, J T Carpenter, et al.
Cancer Treatment Reports|October 1, 1986
Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trialJ T Carpenter, C L Vogel, G Wang, et al.
The Alabama Journal of Medical Sciences|October 1, 1982
Fever of unknown origin, jaundice, hepatosplenomegaly, and pancytopenia in a 36-year-old womanJ H Garcia, J T Carpenter, E Rubin, et al.
Southern Medical Journal|September 1, 1985
Autoimmune hemolytic anemia associated with a hypernephromaP Johnson, R J Gualtieri, D N Mohler, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reports|October 1, 1986
Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: a Southeastern Cancer Study Group trialJ Keller, A Bartolucci, J T Carpenter, et al.
Cancer|August 1, 1991
Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndromeB E Harris, J T Carpenter, R B Diasio
The Journal of Clinical Investigation|January 1, 1988
Familial deficiency of dihydropyrimidine dehydrogenase. Biochemical basis for familial pyrimidinemia and severe 5-fluorouracil-induced toxicityR B Diasio, T L Beavers, J T Carpenter
Virginia Medical|March 1, 1982
Remission of immune hemolytic anemia after removal of ovarian dermoid cyst: case reportM D Murad, D N Mohler, J T Carpenter
Cancer|April 1, 1991
Weight gain with breast cancer adjuvant treatmentE G Levine, J M Raczynski, J T Carpenter
Archives of Internal Medicine|August 1, 1979
Bone marrow necrosis and degenerationM J Norgard, J T Carpenter, M E Conrad
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapyZ Lu, R Zhang, J T Carpenter, et al.
Cancer Treatment Reports|October 1, 1986
Phase II evaluation of fludarabine in patients with metastatic breast cancer: a Southeastern Cancer Study Group trialJ T Carpenter, C L Vogel, G Wang, et al.
The Alabama Journal of Medical Sciences|October 1, 1982
Fever of unknown origin, jaundice, hepatosplenomegaly, and pancytopenia in a 36-year-old womanJ H Garcia, J T Carpenter, E Rubin, et al.
Southern Medical Journal|September 1, 1985
Autoimmune hemolytic anemia associated with a hypernephromaP Johnson, R J Gualtieri, D N Mohler, et al.
Pageof 5